ZA200406245B - Azaspiro compounds for the treatment of pain. - Google Patents

Azaspiro compounds for the treatment of pain.

Info

Publication number
ZA200406245B
ZA200406245B ZA200406245A ZA200406245A ZA200406245B ZA 200406245 B ZA200406245 B ZA 200406245B ZA 200406245 A ZA200406245 A ZA 200406245A ZA 200406245 A ZA200406245 A ZA 200406245A ZA 200406245 B ZA200406245 B ZA 200406245B
Authority
ZA
South Africa
Prior art keywords
amino
amido
sulfonyl
cooh
cho
Prior art date
Application number
ZA200406245A
Other languages
English (en)
Inventor
Claus Meese
Norma Selve
Dirk Schmidt
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of ZA200406245B publication Critical patent/ZA200406245B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54Spiro-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ZA200406245A 2002-03-07 2004-08-05 Azaspiro compounds for the treatment of pain. ZA200406245B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10210190A DE10210190A1 (de) 2002-03-07 2002-03-07 Aza-Spiroverbindungen

Publications (1)

Publication Number Publication Date
ZA200406245B true ZA200406245B (en) 2005-06-13

Family

ID=27771112

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200406245A ZA200406245B (en) 2002-03-07 2004-08-05 Azaspiro compounds for the treatment of pain.

Country Status (19)

Country Link
US (1) US20050288351A1 (enExample)
EP (2) EP1520854A3 (enExample)
JP (1) JP2005526745A (enExample)
KR (1) KR20040091638A (enExample)
CN (1) CN1324011C (enExample)
AT (1) ATE298745T1 (enExample)
AU (1) AU2003215603A1 (enExample)
BR (1) BR0307922A (enExample)
CA (1) CA2477124A1 (enExample)
DE (2) DE10210190A1 (enExample)
ES (1) ES2242944T3 (enExample)
MX (1) MXPA04008669A (enExample)
NO (1) NO20044239L (enExample)
PL (1) PL372431A1 (enExample)
PT (1) PT1485352E (enExample)
RU (1) RU2322438C2 (enExample)
UA (1) UA78987C2 (enExample)
WO (1) WO2003074486A1 (enExample)
ZA (1) ZA200406245B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201607923A (zh) * 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
CN107216335B (zh) * 2017-06-29 2019-04-30 上海药明康德新药开发有限公司 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2866734A (en) * 1956-12-05 1958-12-30 Us Vitamin Corp 3-pyridylethyl 2, 4-oxazolidinediones and process
US3150143A (en) * 1960-07-19 1964-09-22 Geschicketer Fund For Medical Therapeutically active nu-substituted azaspiranes
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3629276A (en) * 1969-07-16 1971-12-21 Abbott Lab 2-amino-5-spiro-substituted-oxazo compounds
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions
GB8916447D0 (en) * 1989-07-19 1989-09-06 Ici Plc Composition,process and use
US5319135A (en) * 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5132451A (en) * 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
RU95114363A (ru) * 1992-11-09 1997-03-20 Дзе Бутс Компани ПЛС. (GB) Производные азаспиросоединений, способ их получения, фармацевтическая композиция, средства для лечения ожирения, средства для лечения аффективных расстройств
US5925672A (en) * 1996-12-06 1999-07-20 Neurosciences Research Foundation, Inc. Methods of treating mental diseases, inflammation and pain
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
US5948807A (en) * 1997-09-03 1999-09-07 Regents Of The University Of Minnesota Spiroindanamines and Spiroindanimides
DE19751062A1 (de) * 1997-11-18 1999-07-08 Univ Ludwigs Albert An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
JP2002516312A (ja) * 1998-05-26 2002-06-04 ワーナー−ランバート・カンパニー カルシウムチャンネルのα2δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物

Also Published As

Publication number Publication date
DE10210190A1 (de) 2003-09-25
CN1639122A (zh) 2005-07-13
RU2004129769A (ru) 2005-07-10
CA2477124A1 (en) 2003-09-12
EP1520854A2 (de) 2005-04-06
MXPA04008669A (es) 2004-12-06
PT1485352E (pt) 2005-10-31
UA78987C2 (en) 2007-05-10
AU2003215603A1 (en) 2003-09-16
CN1324011C (zh) 2007-07-04
HK1080468A1 (zh) 2006-04-28
EP1520854A3 (de) 2007-02-21
WO2003074486A1 (de) 2003-09-12
ATE298745T1 (de) 2005-07-15
NO20044239L (no) 2004-12-01
EP1485352A1 (de) 2004-12-15
AU2003215603A2 (en) 2003-09-16
JP2005526745A (ja) 2005-09-08
KR20040091638A (ko) 2004-10-28
PL372431A1 (en) 2005-07-25
BR0307922A (pt) 2004-12-21
RU2322438C2 (ru) 2008-04-20
US20050288351A1 (en) 2005-12-29
DE50300710D1 (de) 2005-08-04
ES2242944T3 (es) 2005-11-16
EP1485352B1 (de) 2005-06-29

Similar Documents

Publication Publication Date Title
DK0871488T3 (da) Frembringelse af analgetisk synergi ved co-indgivelse af subanalgetiske doser af en mu-opioidagonist og en k2-opioidagonist
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
AP9801302A0 (en) Indole compounds as anti-inflammatory/analgesic agents..
BRPI0407139A (pt) Compostos de amida substituìda por tri(ciclo)
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
RU2008116931A (ru) Применение n-десметилклозапина для лечения нейропсихиатрических заболеваний у людей
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
EA200801165A1 (ru) Антагонисты неосновного рецептора-1 меланинконцентрирующего гормона
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
CY1106763T1 (el) Προληπτικα ή θεραπευτικα μεσα για φλεγμονωδεις νοσους του εντερου
ZA200406245B (en) Azaspiro compounds for the treatment of pain.
MXPA01012558A (es) Compuestos de n-bencensulfonil l-prolina como antagonista de bradiquinina.
PL1648473T3 (pl) Pojedyncza dawka szybko rozpuszczającej się azytromycyny
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
RU2009138028A (ru) Новое профилактическое и/или лекарственное средство против невропатической боли
NO20013480L (no) Legemiddel for torr hud
BR0116724A (pt) Composto, método de tratamento de um distúrbio neurológico ou de uma doença neurodegenerativa, método de tratamento de dor, composição farmacêutica, uso de um composto, e, processos para a preparação e para a sìntese de um composto
EA200500333A1 (ru) Производные r(+)-2-амино-3-гидроксипропионовой кислоты с глицинэргическим действием
BR0307468A (pt) Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas
CA2368184A1 (en) Method and means for treating post-polio syndrome
ECSP982601A (es) Compuestos de indol como agentes antiinflamatorios / analgesicos
UA90264C2 (ru) Три(цикло)замещенные амиды, фармацевтическая композиция, способы лечения и профилактики, способ получения соединения